1. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group workshop Report (April 1996). Br J Dermatol. 1997. 137:327–330.
2. Halevy S, Sukenik S. Different modalities of spa therapy for skin diseases at the Dead Sea area. Arch Dermatol. 1998. 134:1416–1420.
Article
3. Holló P, Gonzalez R, Kása M, Horváth A. Synchronous balneophototherapy is effective for the different clinical types of psoriasis. J Eur Acad Dermatol Venereol. 2005. 19:578–581.
Article
4. Schiffner R, Shifnner-Rohe J, Wölfl G, Landthaler M, Glässl A, Walther T, et al. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol. 2000. 142:740–747.
Article
5. Tsoureli-Nikita E, Menchini G, Ghersetich I, Hercogova J. Alternative treatment of psoriasis with balneotherapy using Leopoldine spa water. J Eur Acad Dermatol Venereol. 2002. 16:260–262.
Article
6. Léauté-Labrèze C, Saillour F, Chêne G, Cazenave C, Luxey-Bellocq ML, Sanciaume C, et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: lessons from the salies de Béarn randomized study. Arch Dermatol. 2001. 137:1035–1039.
7. Dawe RS, Yule S, Cameron H, Moseley H, Ibbotson SH, Ferguson J. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol. 2005. 153:613–619.
Article
8. Zumiani G, Zanoni M, Agostini G. Evaluation of the efficacy of Comano thermal baths water versus tap water in the treatment of eczematous dermatitis. G Ital Dermatol Venereol. 2000. 135:253–258.
9. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996. 106:183–186.
Article
10. Sampogna F, Sera F, Mazzotti E, Pasquini P, Picardi A, Abeni D. IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Study Group. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol. 2003. 139:353–358.
Article
11. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997. 133:1433–1440.
Article
12. Abeni D, Picardi A, Puddu P, Pasquini P, Chren MM. Construction and validation of the Italian version of Skindex-29, a new instrument to measure quality of life in dermatology (in Italian, abstract in English). G Ital Dermatol Venereol. 2001. 136:73–76.
13. Abeni D, Picardi A, Pasquini P, Melchi CF, Chren MM. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology. 2002. 204:43–49.
Article
14. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992. 30:473–483.
15. Piccinelli M, Bisoffi G, Bon MG, Cunico L, Tansella M. Validity and test-retest reliability of the Italian version of the 12-item General Health Questionnaire in general practice: a comparison between three scoring methods. Compr Psychiatry. 1993. 34:198–205.
Article
16. Picardi A, Abeni D, Pasquini P. Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ-12. J Eur Acad Dermatol Venereol. 2001. 15:410–417.
Article
17. Picardi A, Abeni D, Mazzotti E, Fassone G, Lega I, Ramieri L, et al. Screening for psychiatric disorders in patients with skin diseases: a performance study of the 12-item General Health Questionnaire. J Psychosom Res. 2004. 57:219–223.
18. Sampogna F, Tabolli S, Abeni D. IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol. 2007. 157:508–513.
Article
19. Montgomery BJ. Bathing for psoriasis in the Dead Sea. JAMA. 1979. 241:227–231.
Article
20. Even-Paz Z, Shani J. The Dead Sea and psoriasis. Historical and geographic background. Int J Dermatol. 1989. 28:1–9.
21. Abels DJ, Kipnis V. Bioclimatology and balneology in dermatology: a Dead Sea perspective. Clin Dermatol. 1998. 16:695–698.
Article
22. Boer J. The influence of mineral water solutions in phototherapy. Clin Dermatol. 1996. 14:665–673.
Article
23. Wiedow O, Wiese F, Streit V, Kalm C, Christophers E. Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis. J Invest Dermatol. 1992. 99:306–309.
Article
24. Celerier P, Richard A, Litoux P, Dreno B. Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Arch Dermatol Res. 1995. 287:680–682.
Article
25. Olafsson JH, Sigurgeirsson B, Pálsdóttir R. Psoriasis treatment: bathing in a thermal lagoon combined with UVB, versus UVB treatment only. Acta Derm Venereol. 1996. 76:228–230.
26. Gambichler T, Tomi NS, Kreuter A. Controlled clinical trials on balneophototherapy in psoriasis. Br J Dermatol. 2006. 154:802–803.
Article
27. Chiarini A, Dal Pra I, Pacchiana R, Menapace L, Zumiani G, Zanoni M, et al. Comano's (Trentino) thermal water interferes with the expression and secretion of vascular endothelial growth factor-A protein isoforms by cultured human psoriatic keratinocytes: a potential mechanism of its anti-psoriatic action. Int J Mol Med. 2006. 18:17–25.
Article